Drug intelligence / Profile preview

Sperginn

Development stage
Unknown
Lead developer
INNventa Pharm
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Sperginn is a line of dietary supplements developed by INNventa Pharm specifically formulated to support male reproductive health. The product line includes Sperginn Forte and Sperginn Q10, which contain a synergistic blend of amino acids (such as L-arginine, L-carnitine, L-ornithine, and L-citrulline), antioxidants (vitamin C, vitamin E, and coenzyme Q10), and minerals like zinc. These supplements are designed to improve sperm count, motility, and quality, while also supporting normal testosterone levels and addressing symptoms of erectile dysfunction. L-arginine serves as a precursor for nitric oxide production, which is essential for healthy blood flow and erectile function, while the antioxidant components protect sperm cells from oxidative stress and zinc contributes to normal fertility and reproduction.

Brand names
SperginnSperginn ForteSperginn Q10SPERG INN Forte
Other names
Sperginn-INNventa Pharm
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on Sperginn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sperginn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call